Advanced Medical Technology Association: QIAGEN CEO Thierry Bernard Named Chairman of AdvaMedDx Board of Directors
March 25, 2023
March 25, 2023
WASHINGTON, March 25 (TNSper) -- The Advanced Medical Technology Association issued the following news release on March 24, 2023:
AdvaMedDx, a division of AdvaMed representing more than 75 manufacturers of innovative in vitro diagnostic (IVD) tests and technologies in the U.S. and abroad, announced today that Thierry Bernard, CEO of QIAGEN, was elected Chair of the AdvaMedDx Board of Directors. He succeeds Norman Schwartz, CEO of Bio-Rad Laboratories.
Bernard joined QIA . . .
AdvaMedDx, a division of AdvaMed representing more than 75 manufacturers of innovative in vitro diagnostic (IVD) tests and technologies in the U.S. and abroad, announced today that Thierry Bernard, CEO of QIAGEN, was elected Chair of the AdvaMedDx Board of Directors. He succeeds Norman Schwartz, CEO of Bio-Rad Laboratories.
Bernard joined QIA . . .